Consolidated Statements of Operations and Comprehensive Loss (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenues	$ 5,024	$ 2,344
Cost of revenues	(731)	(2,181)
Gross profit	4,293	163
Operating expenses:
Sales and marketing expenses	(286)	(1,100)
General and administrative expenses	(2,549)	(3,593)
Research and development costs	(717)	(951)
Other operating income	229	0
Total operating expenses	(3,323)	(5,644)
Income (loss) from operations	970	(5,481)
Other income (expense):
Gain (loss) from change in fair value of hybrid financial instruments	(197,392)	11,926
Gain from change in fair value of derivative liability - warrants	3,003	11,347
Loss from change in fair value of derivative liability - Series C and D preferred stock and debentures	(21,469)	(13,035)
Gain (loss) on extinguishment of debt	53	(27,479)
Impairment loss on cash surrender value of life insurance policy	0	(527)
Gain on derecognition of accrued expenses and purchase price guarantee	0	8,300
Interest income (expense), net	16	(4,437)
Total other expense	(215,789)	(13,905)
Net loss before taxes	(214,819)	(19,386)
Income tax benefit	706	0
Net loss	(214,113)	(19,386)
Deemed dividends on convertible preferred stock	(16)	0
Deemed dividends on convertible debentures	(726)	0
Net loss available to common shareholders	(214,855)	(19,386)
Comprehensive loss:
Net loss	(214,113)	(19,386)
Foreign currency translation adjustment	133	(56)
Comprehensive loss	$ (213,980)	$ (19,442)
Net loss per share, basic and diluted:
Basic (in dollars per share)	$ (0.05)	$ (0.02)
Fully diluted (in dollars per share)	$ (0.05)	$ (0.02)
Weighted average number of common shares:
Basic (in shares)	4,119,387,609	1,276,601,569
Fully diluted (in shares)	4,119,387,609	1,276,601,569